Patent 11975059 was granted and assigned to Altor BioScience on May, 2024 by the United States Patent and Trademark Office.
The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.